Category Archives: Clinical Cardiology

Patients treated with hydroxychloroquine alone or in combination with azithromycin for pneumonia associated with novel coronavirus disease 2019 (COVID-19) were found to be at increased risk for corrected QT interval (QTc) prolongation, according to study results published in JAMA Cardiology.1 Treatment with hydroxychloroquine or azithromycin has been associated with a risk for prolonged QTc and cardiac dysrhythmias. In this single-center, retrospective, observational cohort study, f 90 patients with COVID-19-associated pneumonia (mean age, 60.116.7 years; 48.9% women; mean body mass index, 31.56.6 kg/m2) who were hospitalized at an academic medical center in Boston, Massachusetts between March 1 and April 7, 2020. Patients in this cohort were treated with hydroxychloroquine for 1 day, with or without azithromycin and had 1 positive COVID-19 polymerase chain reaction test result using nasopharyngeal swabbing. Continue reading →

CLEVELAND, May 19, 2020 /PRNewswire/ -- Axuall, Inc. announced today that it has entered into a strategic collaboration and business alliance with University Hospitals to develop and test new mechanisms and workflows to reduce the time it takes to deploy qualified clinical staff and meet growing patient demand Continue reading →

Nearly 1 in 4 patients with incident venous thromboembolism (VTE) were found not to initiate prescribed anticoagulation therapy in the month following hospital discharge, according to study results published in the American Journal of Medicine. International guidelines recommend that patients who have experienced VTE be treated with anticoagulation therapy for at least 3 months. Yet, a substantial proportion of patients particularly those prescribed warfarin regimens never initiate outpatient pharmacotherapy after a VTE diagnosis. Continue reading →

Multisystem Inflammatory Syndrome in Children is described by the CDC as a troubling new syndrome that may be associated with COVID-19. In its alert, the CDC noted that there is limited information available about MIS-C. Continue reading →

It had all started innocuously enough -- a cough and fever. After that, however, his illness took off. Within a week, he was on a breathing machine in the ICU because of a life-threatening lung infection from Covid-19. Continue reading →

May 19, 2020 16:39 ET | Source: Itamar Medical Ltd. CAESAREA, Israel, May 19, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd Continue reading →

ZOLL Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, announced today it has received CE Mark approval to market and distribute its SuperSaturated Oxygen (SSO2) Therapy System in Europe. SSO2 Therapy provides interventional cardiologists with the first and only clinically proven treatment beyond percutaneous coronary intervention (PCI) to significantly reduce muscle damage in heart attack patients.1 This press release features multimedia. Continue reading →

GHENT, Belgium, May 04, 2020 (GLOBE NEWSWIRE) -- Sequana Medical NV (Euronext Brussels: SEQUA), an innovator in the management of fluid overload in liver disease, malignant ascites and heart failure, today announces the appointment of Oliver Gdje, MD, PhD, as Chief Medical Officer, with immediate effect. Dr Gdje replaces Gijs Klarenbeek, MD, who remains with Sequana Medical as Senior Medical Advisor. Dr Gdje is a highly experienced clinician and medtech industry executive with 18 years of international experience in medical and commercial roles Continue reading →

SAN RAFAEL, Calif., May 3, 2020 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that the company has entered into a preclinical collaboration and license agreement with DiNAQOR AG (DiNAQOR), a gene therapy platform company, to develop novel gene therapies to treat rare genetic cardiomyopathies. Continue reading →

Campus News The Chancellor Charles P. Continue reading →